RSS-Feed abonnieren

DOI: 10.1055/a-2735-4673
Self-administered Follow-up Using a Low-sensitivity Pregnancy Test after Medical Abortion: Results of a Partially Randomized Patient Preference Trial
Artikel in mehreren Sprachen: English | deutschAutor*innen
Gefördert durch: Nordic Pharma Group still needs to be approved
Abstract
Introduction
In Germany, follow-up after medical abortion is typically conducted via ultrasound examination. International evidence suggests that self-administered follow-up using low-sensitivity pregnancy tests may be a safe and acceptable alternative. This study assessed the effectiveness and acceptability of this approach within the German healthcare system.
Methods
In this prospective, multicenter, partially randomized, patient preference study conducted in 11 German centers (March–September 2024) involving 312 women, participants with strong preferences could choose their preferred follow-up method, while all others were randomized to either self-testing or ultrasound follow-up. Follow-up was performed using a low-sensitivity pregnancy test (1000 mIU/ml) at home or by ultrasound examination in the clinic. The primary outcome was the detection of ongoing pregnancies; patient satisfaction was assessed as a secondary outcome.
Results
The detection rate of ongoing pregnancies was 100% in both groups. Specificity was 92.7% in the self-testing group and 100% in the ultrasound group. Complications were rare and occurred at similar rates in both groups. Discordant cases were rare and mainly represented false-positive results with faint test lines near the cut-off; severe complications did not occur more frequently. Satisfaction with the follow-up method was slightly lower in the self-testing group (85.9%) compared to the ultrasound group (98.3%) but remained within an acceptable range. Subjective feelings of safety were high in both groups.
Conclusion
Self-administered follow-up using a low-sensitivity pregnancy test is a safe and well-accepted alternative to ultrasound examination after medical abortion. It may improve access to follow-up care, particularly for women living in underserved or remote areas.
Keywords
outpatient care - medical abortion - follow-up care - low-sensitivity pregnancy test - patient satisfactionPublikationsverlauf
Eingereicht: 07. Juli 2025
Angenommen nach Revision: 29. Oktober 2025
Artikel online veröffentlicht:
08. Dezember 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References/Literatur
- 1 Statistisches Bundesamt (Destatis). Schwangerschaftsabbrüche 2024 nach Ländern und Eingriffsart. Wiesbaden: Statistisches Bundesamt; 2024. Zugriff am 05. Oktober 2025 unter: https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Gesundheit/Schwangerschaftsabbrueche/Publikationen/Downloads-Schwangerschaftsabbrueche/statistischer-bericht-schwangerschaftsabbrueche-2120300247005.xlsx
- 2 Statistisches Bundesamt (Destatis). Schwangerschaftsabbrüche 2000 insgesamt nach Ländern. (Fachserie 12, Reihe 3; ). Wiesbaden: Statistisches Bundesamt; 2000. Zugriff am 05. Oktober 2025 unter: https://www.statistischebibliothek.de/mir/receive/DEHeft_mods_00008540
- 3 Statistisches Bundesamt (Destatis). Schwangerschaftsabbrüche 2014 nach Ländern und Eingriffsart. (Fachserie 12, Reihe 3; ). Wiesbaden: Statistisches Bundesamt; 2014. Zugriff am 05. Oktober 2025 unter: https://www.statistischebibliothek.de/mir/receive/DEHeft_mods_00029491
- 4 Hänel K, Seyler H. S2k-Leitlinie Schwangerschaftsabbruch im ersten Trimenon. Z Allg Med 2023; 99: 133-138
- 5 Tschudin S, Zanotelli D, Bitzer J. et al. Erfahrungen mit dem medikamentösen Schwangerschaftsabbruch, insbesondere Nachkontrolle, Nachbehandlung und nachfolgende Kontrazeption. Geburtshilfe Frauenheilkd 2004; 64: 1299-1304
- 6 Baiju N, Acharya G, D’Antonio F. et al. Effectiveness, safety and acceptability of self-assessment of the outcome of first-trimester medical abortion: a systematic review and meta-analysis. BJOG 2019; 126: 1536-1544
- 7 Cameron ST, Glasier A, Dewart H. et al. Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: a service evaluation. Contraception 2012; 86: 67-73
- 8 Grossman D, Grindlay K. Alternatives to ultrasound for follow-up after medication abortion: a systematic review. Contraception 2011; 83: 504-510
- 9 Raymond EG, Tan YL, Grant M. et al. Self-assessment of medical abortion outcome using symptoms and home pregnancy testing. Contraception 2018; 97: 324-328
- 10 Cameron S. Follow-up after early medical abortion: less is more. BJOG 2019; 126: 1545
- 11 Betreuung nach medikamentösem Schwangerschaftsabbruch. Geburtshilfe Frauenheilkd [Anonym]. 2020; 80: 885-886
- 12 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). Abortion in the first trimester. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/094, May 2022) [Internet]. AWMF. 2022 Zugriff am 29. Juni 2025 unter: http://www.awmf.org/leitlinien/detail/ll/015-094.html
- 13 Hahn D, Torenz R, Thonke I. et al. Zugangsbarrieren zur Schwangerschaftsabbruchversorgung: Eine Analyse aus der Perspektive ungewollt Schwangerer – Erkenntnisse aus der Studie „Erfahrungen und Lebenslagen ungewollt Schwangerer. Angebote der Beratung und Versorgung (ELSA)“. Bundesgesundheitsbl 2024; 68: 28-37
- 14 Torenz R, Vollmer H, Eckardt S. et al. Data on regional availability and accessibility of abortion providers in Germany. Res Health Serv Reg 2023; 2: 21
- 15 Maeffert J, Tennhardt C. Schwangerschaftsabbruch in Deutschland: Gesetzeslage, Herausforderungen und aktuelle Entwicklungen unter Berücksichtigung der COVID-19-Pandemie. Bundesgesundheitsbl 2023; 66: 312-319
- 16 David M, Wernecke KD. Ausgewählte Versorgungsdaten zum Schwangerschaftsabbruch in Deutschland. Frauenarzt 2022; 63: 656-660
- 17 Janotta M. Doctors for Choice. Leserbriefe zu David M, Wernecke KD. Ausgewählte Versorgungsdaten zum Schwangerschaftsabbruch in Deutschland. Frauenarzt 2022; 63: 22-23
- 18 Noor NM, Siegel C. Partially randomised, patient preference trials for inflammatory bowel disease. Lancet Gastroenterol Hepatol 2022; 7: 981-983
- 19 Wasmann KA, Wijsman P, van Dieren S. et al. Partially randomised patient preference trials as an alternative design to randomised controlled trials: systematic review and meta-analyses. BMJ Open 2019; 9: e031151
